HCG promoter Dr. B.S. Ajaikumar holds 3.32% shares encumbered in FY26
Dr. B.S. Ajaikumar, a promoter of HealthCare Global Enterprises Limited, confirmed in a filing that no new encumbrances were created on his shares during FY26. The total encumbered shares remain at 49,59,539, or 3.32% of the paid-up capital, stemming from pledges made in 2021, 2022, and 2025. The promoter also clarified that a recent Promoter Agreement effective May 30, 2025, does not create a third-party encumbrance, despite a prior cautionary disclosure to exchanges.
*this image is generated using AI for illustrative purposes only.
Dr. B.S. Ajaikumar, a promoter of healthcare global enterprises , has declared that no new encumbrances were created on the equity shares held by him during the financial year 2025–2026. The total number of encumbered shares as on March 31, 2026, stands at 49,59,539, representing 3.32% of the paid-up share capital of the company. This disclosure was made to the stock exchanges pursuant to Regulations 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
The promoter detailed the historical encumbrances created in previous financial years, which contribute to the current total. These include 18,92,539 equity shares encumbered on March 12, 2025, and intimated to the exchanges on March 17, 2025. Additionally, 90,000 equity shares were encumbered on September 27, 2022, and 29,77,000 equity shares were encumbered on March 5, 2021, with respective intimations made on September 28, 2022, and March 8, 2021.
Dr. B.S. Ajaikumar confirmed that, other than the disclosed encumbrances, neither he nor the members of his family forming part of the Persons Acting in Concert (PAC) have created any encumbrance, directly or indirectly, on the equity shares of the company during the financial year ended March 31, 2026.
The declaration also referenced a Promoter Agreement dated February 23, 2025, executed between the BSA Promoter Group, Hector Asia Holdings II Pte. Ltd., and KIA EBT II Scheme 1, which became effective on May 30, 2025. Under this agreement, the BSA Promoter Group has undertaken not to transfer or encumber equity securities other than pursuant to specific clauses, including a Permitted Sale or an Eligible Pledge up to 5% of the share capital.
While the agreement records inter se rights and obligations, it does not create a third-party interest or encumbrance on the shares. A disclosure was made to the stock exchanges on June 9, 2025, as a matter of abundant caution regarding the broad definition of "encumbrance" under the SAST Regulations. Consequently, the number of encumbered shares remains unchanged following the effectiveness of the Promoter Agreement.
Details of Encumbrances
| Date of Encumbrance | Number of Shares Encumbered | Date of Intimation to Exchanges |
|---|---|---|
| March 12, 2025 | 18,92,539 | March 17, 2025 |
| September 27, 2022 | 90,000 | September 28, 2022 |
| March 5, 2021 | 29,77,000 | March 8, 2021 |
| Total as on March 31, 2026 | 49,59,539 | 3.32% of paid-up share capital |
Historical Stock Returns for Healthcare Global Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.89% | -3.34% | -3.52% | -12.57% | +14.10% | +205.98% |
What are the specific purposes for which the historical encumbrances were created, and are there plans to release them in the near future?
How will the restrictions in the Promoter Agreement regarding the transfer of shares impact the liquidity and free float of Healthcare Global Enterprises?
Does the 'Eligible Pledge' clause allowing up to 5% encumbrance indicate potential plans by the promoter to raise capital for personal or corporate purposes?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
